Clinical Study on Options of Medication Regimen in Treatment of Refractory Obsessive-Compulsive Disorder Patients

Condition:   Obsessive-Compulsive Disorder Interventions:   Drug: Sertraline 200 milligram(mg);   Drug: Sertraline 300 milligram(mg);   Drug: Fluvoxamine;   Drug: Venlafaxine;   Drug: Augment with Memantine;   Drug: Augment with Aripiprazole Sponsors:   Shanghai Mental Health Center;   The first specialized hospital of harbin;   Guizhou Provincial People's Hospital;   First Affiliated Hospital of Jinan University;   West China Hospital;   Suzhou Psychiatric Hospital;   Nanjing Medical University;   Wuhan Mental He alth Centre;   Hangzhou Seventh People's Hospital;   The First Affiliated Hospital of Kunming Medical College;   General Hospital of Ningxia Medical University;   The First Affiliated Hospital of Nanchang University;   Henan Mental Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials